89bio, Inc. Files 8-K on Security Holder Vote Matters
| Field | Detail |
|---|---|
| Company | 89bio, Inc. |
| Form Type | 8-K |
| Filed Date | May 30, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
Related Tickers: BIO
TL;DR
89bio (BIO) is calling a shareholder vote - details to follow.
AI Summary
On May 28, 2025, 89bio, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The filing does not contain specific details about the matters to be voted on or any associated financial implications.
Why It Matters
This filing signals that 89bio, Inc. is convening its security holders for a vote, which could pertain to significant corporate actions or governance changes.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose specific material events or financial changes.
Key Players & Entities
- 89bio, Inc. (company) — Registrant
- May 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39122 (identifier) — Commission File Number
- 655 Montgomery Street, Suite 1500, San Francisco, CA 94111 (address) — Principal executive offices
FAQ
What specific matters will be presented for a vote to 89bio, Inc.'s security holders?
The filing does not specify the exact matters to be voted on, only that a submission of matters to a vote of security holders is being reported.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 28, 2025.
What is the principal executive office address for 89bio, Inc.?
The principal executive offices are located at 655 Montgomery Street, Suite 1500, San Francisco, CA 94111.
Under which state is 89bio, Inc. incorporated?
89bio, Inc. is incorporated in Delaware.
What is the Commission File Number for 89bio, Inc.?
The Commission File Number for 89bio, Inc. is 001-39122.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding 89bio, Inc..